Product
Etoricoxib
Aliases
Comparator drug 2, Etoricoxib 60 mg, etoricoxib 90 mg (Arcoxia®) +FDC placebo, MK-0663
8 clinical trials
12 indications
Indication
Tooth ExtractionIndication
GoutIndication
AcupunctureIndication
PainIndication
OsteoarthritisIndication
KneeIndication
Chronic lower back painIndication
Ankylosing spondylitisIndication
Wound InfectionIndication
Postoperative PainIndication
ArthritisIndication
RheumatoidClinical trial
Parallel-Group,Double-Blind,Double-Dummy,Superiority Study of Etoricoxib90mg/ Cyclobenzaprine15mg From Eurofarma Versus Etoricoxib90mg (Arcoxia®) and Cyclobenzaprine15mg (XL - Mitrul®) for Muscle Spasm After Third Molar Extraction in BrazilStatus: Withdrawn, Estimated PCD: 2027-10-30
Clinical trial
Immediate Analgesic Effects of Cheek Acupuncture for Acute Gouty ArthritisStatus: Recruiting, Estimated PCD: 2023-12-31
Clinical trial
A Study to Assess the Single Dose Pharmacokinetics of Two and Proof of Efficacy of One New Etoricoxib Gel Formulation in Osteoarthritis PatientsStatus: Completed, Estimated PCD: 2014-11-26
Clinical trial
Biomarkers for Prediction of Analgesic Efficacy Based on Interrelations Between Pain Modulation and EEG vs. Drugs' Mode of Action in Knee OAStatus: Completed, Estimated PCD: 2024-04-07
Clinical trial
The Effect of Low Dose Pregabalin and Etoricoxib Combination on Pain in Comparison to Etoricoxib Alone in Patients Suffering From Chronic Low Back PainStatus: Not yet recruiting, Estimated PCD: 2024-10-31
Clinical trial
A Phase III, Two-Part, Randomized, Double-Blind, Active Comparator-Controlled, Multicenter Clinical Trial to Study the Relative Efficacy and Tolerability of Two Doses of MK-0663/Etoricoxib in Patients With Ankylosing SpondylitisStatus: Completed, Estimated PCD: 2014-11-12
Clinical trial
Preemptive Use of Etoricoxib and Dexamethasone: Effect on Early Bone Healing, Inflammatory Response, and Postoperative Parameters After Impacted Lower Third Molar SurgeryStatus: Completed, Estimated PCD: 2022-12-26
Clinical trial
A Phase III, Two-Part, Randomized, Double-Blind, Placebo-Controlled, Multicenter Clinical Trial to Assess the Relative Efficacy and Tolerability of Two Doses of MK-0663/Etoricoxib in Patients With Rheumatoid ArthritisStatus: Completed, Estimated PCD: 2014-06-09